2752352-90-0
2752352-90-0
Chemical Structure
KRAS G12C inhibitor 30
- CAS. Nr.: 2752352-90-0
- Formula:C25H22ClFN6O3
- Molecular Weight:508.93
IUPAC Name: N-(3-(3-(2-chloro-6-fluorobenzyl)-1-methyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-f]purin-9(6H)-yl)phenyl)acrylamide
InChIKey: FYTIAUJXQNHTOR-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=CC(N2C3=NC4=C(N3CCC2)C(N(CC5=C(Cl)C=CC=C5F)C(N4C)=O)=O)=C1)C=C
Biological Activity: KRAS G12C inhibitor 30 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 2. KRAS G12C inhibitor 30 can be used for the research of cancer[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KRAS G12C inhibitor 30 | KRAS G12C inhibitor 30 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 2. KRAS G12C inhibitor 30 can be used for the research of cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
